PDE5 Inhibitors Enhance the Lethality of [Pemetrexed + Sorafenib]
Oncotarget - United States
doi 10.18632/oncotarget.14562
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 9, 2017
Authors
Publisher
Impact Journals, LLC
Available in full text
January 9, 2017
Impact Journals, LLC